DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Gemcabene is an investigational drug.
There have been 12 clinical trials for Gemcabene. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 1999.
The most common disease conditions in clinical trials are Hypercholesterolemia, Hypertriglyceridemia, and Non-alcoholic Fatty Liver Disease. The leading clinical trial sponsors are Gemphire Therapeutics, Inc., Elif Oral, and Emory University.
Recent Clinical Trials for Gemcabene
|Gemcabene for the Treatment of Pediatric NAFLD||Gemphire Therapeutics, Inc.||Phase 2|
|Gemcabene for the Treatment of Pediatric NAFLD||Emory University||Phase 2|
|Study of Gemcabene in Adults With FPLD||Elif Oral||Phase 1/Phase 2|